Restoring success where once was thought only failure lay: The viability of functional rehabilitation for people with cognitive impairment

Journal of the American Geriatrics Society

Volumn 53, Issue 9, 2005, Pages 1624-1626

  Thomas, Vince S ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DISABILITY; EDITORIAL; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MEDICARE; MORTALITY; PHYSICAL CAPACITY; PRACTICE GUIDELINE; AGED; NOTE; NURSING; OUTPATIENT DEPARTMENT;

AGED; AMBULATORY CARE FACILITIES; COGNITION DISORDERS; HUMANS;

EID: 27744466560     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2005.53456.x     Document Type: Editorial

References (21)

1. OASDI Trustees Report. Social Security Administration, 2003 [on-line]. Available at www.ssa.gov/OACT/TR/TR03/index.html Accessed December 2003.
2. Lakdawalla D, Goldman DP, Battacharya J et al. Forecasting the nursing home population. Med Care 2003;41:8-20.
3. Lakdawalla D, Battacharya J, Goldman DP. Are the young becoming more disabled? Health Aff (Millwood) 2004;23:168-176.
4. Lubitz J, Cai L, Kramarow E et al. Health, life expectancy, and health care spending among the elderly. N Engl J Med 2003;49:1048-1055.
5. Taylor DH Jr, Sloan FA. How much do persons with Alzheimer's disease cost Medicare? J Am Geriatr 2000;48:639-646.
6. Barberger-Gateau P, Fabrigoule C. Disability and cognitive impairment in the elderly. Disabil Rehabil 1997;19:175-193.
7. Galasko D, Edland S, Morris J et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical Milestones in patients with Alzheimer's disease followed over 3 years. Neurology 1995;45:1451-1455.
8. Aguero-Torres H, Thomas VS, Winblad B et al. The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol 2002;55:1007-1012.
9. Mortimer J, Ebbitt B, June S-P et al. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696.
10. Yu F, Evans LK, Sullivan-Marx EM et al. Functional outcomes for older people with cognitive impairment in a comprehensive outpatient rehabilitation facility. J Am Geriatr Soc 2005;53:1599-1606.
11. Jackson O, Senile dementia and cognitive impairment. In: Kauffman T, ed. Geriatric Rehabilitation Manual. New York: Churchill Livingstone, 1999, pp 136-142.
12. Dvorak RV, Poehlman ET. Appendicular skeletal muscle mass, physical activity and cognitive status in patients with Alzheimer's disease. Neurology 1998;51:1386-1390.
13. Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci 1998;854:378-393.
14. Singh NA, Clements KM, Singh MA. The efficacy of exercise as a long-term antidepressant in elderly subjects: A randomized, controlled study. J Gerontol A Biol Sci Med Sci 2001;56A:M497-M504.
15. Thomas VS, Hageman PA. Reliability of physical performance measures in elderly day-care center clients with dementia. Int Psychogeriatr 2002;14:17-24.
16. Tappen RM, Roach KE, Buchner D et al. Reliability of physical performance measures in nursing home residents with Alzheimer's disease. J Gerontol A Biol Sci Med Sci 1997;52A:M52-M55.
17. Hageman PA, Thomas VS. Gait performance in dementia. The effects of a 6-week resistance training program in an adult day-care setting. Int J Geriatr Psychiatr 2002;17:329-334.
18. Thomas VS, Hageman PA, Can neuromuscular weakness in people with dementia be rehabilitated using resistance exercise training? Results from a preliminary intervention study. J Gerontol A Biol Sci Med Sci 2003;58A: 746-751.
19. Thomas VS, Petzel JB. Can (resistance) exercise training improve cognitive and physical function in an elderly patient with dementia? A case report. Brain Aging 2004;4:41-45.
20. Borst SE, De Hoyos DV, Garzarella L et al. Effects of resistance training on insulin-like growth factor-I and IGF binding proteins, Med Sci Sports Exerc 2001;33:648-653.
21. Carro E, Trejo JL, Gomez-Isla T et al. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002;8:1390-1397.